Business · 20/04/2009Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting to Discuss Risk Evaluation and Mitigation Strategies for Opioid Drugs
Summary
The FDA is hosting a public meeting to gather input on developing strategies to minimize risks associated with certain opioid medications, while ensuring their benefits continue to outweigh these risks.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →